Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement with Xiaoshou Medical Technology Co., Ltd. The company was founded in 1988 and is based in Beijing, the People's Republic of China.
Frequently asked questions
What sector does Biosino Bio-Technology and Science Incorporation (8247) operate in?
Biosino Bio-Technology and Science Incorporation belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Biosino Bio-Technology and Science Incorporation (8247) current stock price?
As of the latest data, Biosino Bio-Technology and Science Incorporation stock price is HK$3.02, with a previous close of HK$3.02.
What is Biosino Bio-Technology and Science Incorporation (8247) current market capitalization?
Biosino Bio-Technology and Science Incorporation market cap is approximately 194.14 million.
Does Biosino Bio-Technology and Science Incorporation (8247) pay dividends?
No. Biosino Bio-Technology and Science Incorporation does not pay a dividend.
What is Biosino Bio-Technology and Science Incorporation (8247) beta (volatility) score?
Biosino Bio-Technology and Science Incorporation has a beta of 0.522, indicating lower volatility than the overall market.